|
|
|
|
Vol. 10, Issue 7, 2209-2219, July 1999

*Department of Tumor Cell Biology, St. Jude Children's Research
Hospital, Memphis, Tennessee 38105; and
Department of
Biochemistry, University of Tennessee, Memphis, Tennessee 38163
| |
ABSTRACT |
|---|
|
|
|---|
The immunoglobulin (Ig) molecule is composed of two identical heavy chains and two identical light chains (H2L2). Transport of this heteromeric complex is dependent on the correct assembly of the component parts, which is controlled, in part, by the association of incompletely assembled Ig heavy chains with the endoplasmic reticulum (ER) chaperone, BiP. Although other heavy chain-constant domains interact transiently with BiP, in the absence of light chain synthesis, BiP binds stably to the first constant domain (CH1) of the heavy chain, causing it to be retained in the ER. Using a simplified two-domain Ig heavy chain (VH-CH1), we have determined why BiP remains bound to free heavy chains and how light chains facilitate their transport. We found that in the absence of light chain expression, the CH1 domain neither folds nor forms its intradomain disulfide bond and therefore remains a substrate for BiP. In vivo, light chains are required to facilitate both the folding of the CH1 domain and the release of BiP. In contrast, the addition of ATP to isolated BiP-heavy chain complexes in vitro causes the release of BiP and allows the CH1 domain to fold in the absence of light chains. Therefore, light chains are not intrinsically essential for CH1 domain folding, but play a critical role in removing BiP from the CH1 domain, thereby allowing it to fold and Ig assembly to proceed. These data suggest that the assembly of multimeric protein complexes in the ER is not strictly dependent on the proper folding of individual subunits; rather, assembly can drive the complete folding of protein subunits.
| |
INTRODUCTION |
|---|
|
|
|---|
Immunoglobulin (Ig) molecules are the cornerstone of humoral
immunity, playing essential roles as both membrane-bound receptor complexes in the development and activation of B lymphocytes and as
secreted effector molecules. In addition, Ig molecules provide an
excellent model for studies concerning the biosynthesis of multimeric
protein complexes and the role of molecular chaperones in the folding
and assembly of the individual protein subunits that form higher-order
structures. In their simplest form, Igs are comprised of two identical
heavy chains disulfide bonded to two identical light chains, forming an
H2L2 molecule. Crystallographic analyses and in
vitro folding studies indicate that each chain consists of a series of
Ig domains that fold independently of each other (Goto and Hamaguchi,
1982
; Lilie et al., 1995
) into a compact structure composed
of two twisted
sheets stabilized by a single disulfide bond (Amzel
and Poljak, 1979
). Developmentally, Ig heavy chains are synthesized
before conventional light chain (LC) genes are rearranged and
expressed. In pre-B cells, the heavy chains form homodimers (Kaloff and
Haas, 1995
); however, without LCs they are efficiently retained in the
endoplasmic reticulum (ER) due to their association with the ER
chaperone, BiP (Haas and Wabl, 1983
; Bole et al., 1986
).
Initiation of LC protein expression allows the formation of
H2L2 molecules. As is true of many other multimeric proteins, this assembly occurs in the ER, and incorrectly or
incompletely assembled Ig molecules remain bound to BiP and are
eventually targeted for degradation (Sitia et al., 1990
;
Gardner et al., 1993
; Knittler et al., 1995
).
BiP was first identified as a resident ER protein associated with
incompletely assembled Ig heavy chains (Haas and Wabl, 1983
; Bole
et al., 1986
). Subsequent studies have shown that BiP is expressed in all cell lineages (Bole et al., 1986
) and
associates transiently with numerous secretory pathway proteins and
more stably with mutant counterparts of these proteins (Gething and Sambrook, 1992
). This promiscuous binding suggests that BiP does not
recognize a unique linear amino acid sequence. In vitro studies revealed that BiP preferentially binds peptides with the heptameric motif of HyXHyXHyXHy, where Hy is a bulky aromatic or hydrophobic residue and X is any amino acid (Blond-Elguindi et al.,
1993
). The alternating pattern of hydrophobic residues in the binding motif is compatible with BiP binding to proteins when they are in an
extended conformation, in which the bulky aromatic/hydrophobic side
chains lie on one side of the protein and presumably point into the
protein-binding site of BiP. It is believed that these hydrophobic
residues would be buried upon protein folding, thus providing a
mechanism for the transient interaction of nascent proteins with BiP
and the more stable association of mutant proteins that are defective
in folding.
Although BiP binds transiently to the subunits of a wide variety of
multimeric proteins (Gething and Sambrook, 1992
), its associations with
Ig heavy and light chains are among the best characterized. BiP binds
transiently to the nascent Ig LC in vivo when the variable region is in
an unfolded state (Hendershot et al., 1996
; Skowronek
et al., 1998
; Hellman et al., 1999
), which is in
keeping with the predictions from the peptide-binding studies, and
releases as the domain folds. Although BiP can bind transiently to
multiple heavy-chain domains (Kaloff and Haas, 1995
), the stable BiP
binding site on unassembled heavy chains is the CH1 domain (Hendershot et al., 1987
), which is involved in both
hydrophobic and covalent interactions with the CL domain of
the LC. Unlike wild-type (WT) heavy chains, mutants that lack the
CH1 domain can be secreted as partially assembled molecules
(Hendershot et al., 1987
), demonstrating that BiP regulates
the transport of assembling Ig molecules. The reason that BiP binds
stably to the CH1 domain, but only transiently or not at
all with other Ig domains, is not understood. It is possible that BiP
can bind to both linear hydrophobic stretches on nascent chains before
they fold (e.g., VL) and to hydrophobic faces on folded
protein subunits before they assemble into multimeric complexes (e.g.,
CH1 of Ig heavy chain). Conversely, BiP may bind to
unfolded regions of the proteins in both cases if the CH1
domain is unable to fold until it successfully pairs with a LC. Because
transport of the Ig heavy chain appears to be central to the fidelity
of B cell development and the integrity of the antibody response and
because Ig molecules can serve as a paradigm for the mechanisms that
control subunit assembly of multimeric proteins, we have defined, at
the molecular level, the sequence of events that control Ig assembly
and transport. We demonstrate that BiP and LC cooperate to ensure that
only properly assembled Ig molecules are transported from the ER by
controlling the final folding of the heavy chain.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Construction of Ig Heavy-Chain Mutants
CH1 Deletion Mutant.
To produce the various
heavy-chain constructs needed for these analyses, we started with a
chimeric mouse-human
heavy chain cDNA (generously provided by Dr.
Randy Robinson, Xoma Corporation) that we have used previously for
transient expression and BiP-binding experiments. The chimeric cDNA was
constructed by joining the variable region from a mouse monoclonal
antibody to the last five amino acids of a human J gene and the
constant region of the human
1 gene (Liu et
al., 1987
). We removed the CH1 domain from this construct using the deletional overlap-extension PCR method (Ho et al., 1989
). Oligonucleotides were designed to produce
in-frame joining of the final residue of the variable region,
Ser113, with the first amino acid of the hinge region,
Glu212. The PCR product was digested with XhoI
and SacII and ligated into the chimeric
cDNA in place of
the WT sequence. The entire cDNA clone was sequenced before it was
recloned into the pSVL eucaryotic expression vector
(
CH1) for use in transfection studies. The deletion
was based on a murine plasmacytoma in which the CH1 exon
was removed by an alternative splice that occurred due to a mutation in
the splice acceptor of the CH1 domain (Brandt et
al., 1984
). It was anticipated that this cDNA would encode a heavy
chain mutant that would dimerize and be secreted in the absence of LC
association (Morrison, 1978
; Hendershot et al., 1987
).
V-CH1 Truncation Mutant.
Using the chimeric
heavy-chain cDNA, we produced a truncation mutant that was comprised of
only the variable and CH1 domain. This was accomplished by
PCR amplification of a region between the AspI site in
the CH1 domain and the end of the CH1
domain-coding sequence. The 3'-oligo was designed to incorporate a stop
codon immediately after the 3'-end of the domain
(valine211) followed by a BamHI site. The
product was digested and inserted into the heavy-chain cDNA in place of
the original sequence. After sequencing, the truncated cDNA was
inserted into the pSVL eucaryotic expression vector
(
CH1). In addition to lacking the CH2 and
CH3 domains, the truncation mutant no longer contained the
hinge region that includes the cysteine residue required for covalent
attachment of LC and the cysteine residues involved in heavy-chain
dimerization. Two copies of a nine-amino acid epitope (YPYDVPDYA) from
the influenza hemagglutinin protein (HA-tag) were added to its carboxy
terminus. This was accomplished by first amplifying the variable and
CH1 domains using T7 as the 5'-primer and
GGAATTCAGCCCGTAGTCTGGGACGTC-GTATGGGTAT TGGCCAACTTTCTTGTCCACCTTGG as the 3'-primer. The
MscI and EcoRI sites are underlined, the sequence
encoding the tag is in boldface type, and the sequence complementary to
the end of the CH1 domain is in lightface type. The PCR
product was cut with XhoI and EcoRI and inserted
into the pBEX vector, which places it immediately upstream and in frame
with the HA-tag epitope. A second construct was made with a single
epitope tag, by cutting the PCR product with XhoI and
MscI and inserting into pBEX. This removed the tag from the
PCR product and allowed in-frame insertion upstream of the HA-tag. Both
were analyzed and provided similar experimental results; only data on
the double-tagged truncation mutant are presented here because its size
was more easily distinguished from the
LC. The tagged construct was
sequenced and recloned into pSVL (HA-
CH1) for transient
expression experiments.
Transient Expression and Immunoprecipitations
The various
heavy chain constructs were transiently
expressed along with either WT or ATPase mutant hamster BiP cDNAs (Wei et al., 1995
). Although BiP is already present in the COS
cells, we cotransfected cells with a cDNA encoding hamster BiP in some experiments to ensure that BiP levels were not limiting. To examine the
requirement for LCs in BiP release and heavy-chain folding, cDNAs
encoding various LC constructs were cotransfected with the truncated
heavy chains. These included either WT
I LC, mutant LCs that are
unable to complete folding of either the variable domain
(Vmut) or constant domain (Cmut) due to
pair-wise substitution of serine residues for the cysteine residues
involved in intradomain disulfide bond formation (C41 and
C109 in the variable domain and C156 and
C212 in the constant domain), or an ER-targeted constant domain (Hellman et al., 1999
) construct. A cDNA encoding the
NS-1
LC (Skowronek et al., 1998
) was used as a control
to monitor the effects of BiP release on domain folding and oxidation.
COS-1 cells (2.5 × 106) were plated in 60-mm plastic
dishes and transfected the following day by the DEAE-Dextran method as
described previously (Hendershot et al., 1995
). The
constructs used in each experiment are indicated in the description of
our results and the figure legends.
Cells were metabolically labeled with [35S] Translabel
(ICN, Irvine, CA) 40 h after transfection, as indicated in RESULTS
and figure legends. When labeled proteins were analyzed under reducing conditions, cells were washed twice with ice-cold PBS and lysed in our
standard lysing buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 0.5%
deoxycholic acid, and 0.5% NP40). When labeled proteins were analyzed under nonreducing conditions, cells were washed first with
ice-cold PBS containing 20 mM N-ethylmaleimide (NEM)
before lysing. NEM (20 mM) and apyrase (10 U/ml) were included in the lysing buffer. Variations in labeling and lysing conditions are detailed in RESULTS and figure legends. Labeled lysates were
immunoprecipitated with either a polyclonal rabbit anti-rodent BiP
antiserum (Hendershot et al., 1995
), a monoclonal anti-BiP
antibody (Bole et al., 1986
), a polyclonal goat anti-mouse
or goat anti-human
antiserum (Southern Biotechnology
Associates, Birmingham, AL), or a monoclonal antibody to the HA epitope
(a kind gift of Dr. Al Reynolds, Vanderbilt University). Immune
complexes were precipitated by binding to protein A-Sepharose beads
(Sigma Chemical, St. Louis, MO). Proteins were resolved on
SDS-polyacrylamide gels under either reducing or nonreducing conditions
and visualized by fluorography using the Amplify Reagent (Amersham,
Arlington Heights, IL).
BiP was released in vitro from the truncated heavy chain and the
NS-1
LC by omitting NEM and apyrase from the lysing buffer and
incubating the cell lysate with 2 mM Mg-ATP and 25 mM KCl at room
temperature for 30 min. Heavy and light chains were immunoprecipitated with chain-specific antisera and analyzed on nonreducing gels to
monitor oxidation of the CH1 and VL domains, respectively.
| |
RESULTS |
|---|
|
|
|---|
Is the Interaction of Mouse Heavy Chains with BiP in COS Fibroblast Cells Similar to That Described for Mouse Lymphoid Cells?
To examine the "stable" binding of BiP with the
CH1 domain of unassembled Ig heavy chains, we wished to use
the COS transient expression system, which is a much more tractable
approach for examining numerous different constructs and combinations
of them. First, we needed to ensure that monkey BiP would bind stably
to the CH1 domain of the mouse Ig heavy chain and prevent
its secretion as it does in mouse plasmacytomas (Hendershot et
al., 1987
). We produced an in-frame deletion mutant of the
heavy chain that eliminated the CH1 domain
(
CH1) but retained the hinge region that controls
heavy chain dimerization. This construct was modeled on a mouse myeloma
protein that no longer binds stably to BiP and can be secreted in the
absence of LC pairing (Morrison, 1978
; Brandt et al., 1984
;
Hendershot et al., 1987
). cDNAs encoding the full-length
heavy chain and the 
CH1 mutant were transiently expressed in COS monkey fibroblast cells. The WT heavy chains associated with BiP and were not secreted during the 2-h labeling period (Figure 1A), which is consistent
with heavy chain expression in mouse plasmacytoma lines (Bole et
al., 1986
; Hendershot et al., 1987
). When cells
expressing the 
CH1 mutant were similarly analyzed, we
found that although there was detectable association of the mutant
heavy chain with BiP in the cell lysates, deletion of the
CH1 domain allowed the heavy chain to be secreted without LC assembly (Figure 1A). Again, this is consistent with studies in
mouse lymphoid lines that demonstrated BiP can bind transiently to
other heavy chain domains (Kaloff and Haas, 1995
), but that the
CH1 domain is responsible for the stable interaction with BiP (Hendershot et al., 1987
), which results in the
retention of unassembled heavy chains (Morrison, 1978
; Seligmann
et al., 1979
). This conclusion was further supported by data
obtained when the CH1 domain mutant was coexpressed with a
BiP ATPase mutant (G37) that acts as a kinetic trap for substrate
proteins (Hendershot et al., 1996
). In the presence of
mutant BiP expression, there was an increase in the amount of BiP
coprecipitating with the CH1-deleted heavy chain and a
small decrease in its secretion (Figure 1B). This is consistent with
BiP interacting transiently with some of the other heavy chain domains
(Kaloff and Haas, 1995
) and distinguishing BiP's interaction with the
CH1 domain (continuous) from that with the other Ig domains
(transient). The fact that mutant BiP expression does not completely
block the secretion of the CH1-deleted heavy chain
demonstrates that the other domains on most of the chains must fold
independently of BiP and that only a small portion of them binds to
BiP. Thus, it appears that COS cells functionally recapitulate the
binding of BiP to Ig heavy chains and provide a suitable system for
studying this interaction.
|
Can a Two-Domain Heavy Chain Be Created for Folding Studies That
Mimics a Full-Length
?
To analyze the interaction of BiP with the CH1 domain
of free heavy chains, we wanted to be able to determine the folding status of this domain. One way to do this is to monitor the oxidation status of the domain, which is dependent on it folding correctly and
can be assessed by the mobility of the protein on nonreducing gels
(Hendershot et al., 1996
; Hellman et al., 1999
).
However, full-length Ig heavy chains form disulfide-linked dimers that migrate at ~110 kDa, making it difficult to monitor the folding of
individual domains. Additionally, any changes in folding that might
occur upon assembly with LCs could not be monitored by this type of
analysis, since the LCs are covalently attached to the heavy chains via
disulfide bonds. Thus, we constructed a simpler "heavy chain" for
folding studies. We produced a two-domain heavy chain with a stop codon
immediately 3' of the CH1 coding region (
CH1), thereby removing the hinge region that includes
the cysteine residues involved in heavy chain dimerization and in
covalent attachment of LC. Although this truncated heavy chain could be coprecipitated with BiP, the anti-
antiserum was unable to recognize it (our unpublished results), making it impossible to monitor secretion
of the smaller free heavy chain. When
LCs were also coexpressed, we
found that the truncated heavy chain could combine with LC (albeit
noncovalently) and be secreted, but again it was impossible to
determine the efficiency of this reaction. To facilitate the
immunoprecipitation studies of the truncated heavy chain, we added an
epitope from the influenza hemagglutinin (HA) protein to the C
terminus of the truncated heavy chain (HA-
CH1). cDNAs encoding either WT heavy chain or the truncated HA-
CH1
protein were coexpressed with either WT hamster BiP or
LCs. In the
absence of LC expression, both the full-length and truncated heavy
chains were retained in the cell (Figure
2). In both cases, BiP was coprecipitated with the heavy chains. Care must be taken in overinterpreting the
relative signals in the various immunoprecipitation reactions. Less
labeled BiP is coprecipitated with the truncated heavy chains, in part,
because the steady state level of these mutant heavy chains is lower
than the full-length
chain. This is due to a combination of their
somewhat lower rate of synthesis and their reduced stability (our
unpublished results). Additionally, the amount of full-length heavy
chain found in the anti-BiP lane is not a clear indication of their
coprecipitation with BiP, because these heavy chains bind directly to
protein A-Sepharose beads. The truncated heavy chains do not bind to
protein A because the CH3 domain is no longer present. When
these two heavy chains were coexpressed with LCs, we found that in both
cases they readily assembled with the LC and were secreted (Figure 2).
Thus, the epitope-tagged truncated heavy chain behaved like a
full-length heavy chain in these assays, making them a reasonable model
to analyze the folding status of the CH1 domain in free,
nontransported heavy chains.
|
Is the BiP-bound CH1 Domain Folded or Unfolded?
To understand the reason for stable BiP binding to the
CH1 domain on free heavy chains, we determined whether BiP
remains bound to the CH1 domain because this domain is
unable to fold in the absence of LC or, alternatively, whether BiP is
also capable of binding hydrophobic faces on folded proteins. We
reasoned that a folded CH1 domain might possess exposed
hydrophobic patches before assembly with LC. The oxidation status of an
Ig domain can readily be assessed by examining its mobility on a
nonreducing SDS gel. As these domains fold and are oxidized, their
mobility increases such that it is possible to distinguish between
two-domain chains with neither, one, or both domains folded (Hendershot
et al., 1996
). The HA-tagged truncated heavy chain was
labeled in the presence of DTT to provide a marker for its mobility as
a completely reduced protein (Figure 3,
lane 1). WT hamster BiP was cotransfected into the cells to ensure that
BiP levels were not limiting. The truncated heavy chains labeled in the
absence of DTT clearly migrated faster than the fully reduced chains
(lanes 2 and 3). It was not immediately clear whether the faster
mobility was due to one or both domains possessing disulfide bonds.
Therefore, the mobility of the free truncated heavy chain was compared
with that of its fully assembled and secreted counterpart, which should be completely oxidized. Three Ig species were detected in cells expressing both LC and HA-
CH1 when the anti-HA antibody
was used (lane 6). The slowest species comigrated with the free
truncated heavy chain, the fastest represented the
LC, and the
intermediate band represented the mature, fully oxidized
HA-
CH1. This species coprecipitated with LC (lane 8) but
not BiP (lane 7) and was secreted noncovalently associated with the LC
(lane 5). These data indicate that a single domain (CH1)
remains unfolded in free heavy chains that have not assembled with LC,
thus providing a persistent site for BiP interaction. Furthermore, they
suggest that LCs are somehow involved in the folding of the
CH1 domain.
|
What Are the LC Structural Requirements for Inducing BiP Release and CH1 Domain Folding?
Because BiP associates with the variable domain of the LC during
the course of its folding (Hellman et al., 1999
), we
determined whether it was essential that both domains of the LC be able
to fold before it could "help" the CH1 domain fold or
whether two partially folded heavy and light chains could interact and
aid the folding of each other's corresponding domain. We made use of
two
LC mutants that were unable to complete the folding of either
their V or C domain due to pair-wise mutation of the cysteine residues
involved in intradomain disulfide bond formation (Hellman et
al., 1999
). Because these mutant LCs fold only a single domain, they migrate slower than the WT
LC on nonreducing gels (Figure 4, lane 9). The truncated heavy chain was
expressed alone (to serve as a marker for the partially folded
molecule), or together with WT, Vmut, or Cmut
LC. The Vmut LC was expressed alone to serve as a
marker for the partially folded LC. While expression of the WT LC
induced folding and assembly of approximately half of the truncated
heavy chains (Figure 4, lanes 3 and 4), neither of the LC mutants was
able to associate stably with HA-
CH1 or induce its
folding (Figure 4). When the same analysis was repeated under reducing
conditions, we detected a very small amount of both the V and C domain
mutants coprecipitating with the truncated heavy chain (our unpublished
results). The absence of signals representing coprecipitation on the
nonreducing gel suggests that these complexes must be nonproductive
aggregates that do not enter the gel under nonreducing conditions. This
might explain the weaker signal that is observed for both heavy and
light chains (compare lanes 3, 5, and 7 for heavy chain and lanes 6, 8, and 9 for LC) in the lanes corresponding to LC mutants. These data show
that both LC domains must be capable of folding for the LC to
contribute to BiP release and folding of the CH1 domain.
|
Can an Isolated, Folded CL Domain Bind to and Allow the CH1 Domain to Fold as Might Occur in the pre-B Cell Ig Receptor?
The failure of the V and C mutant LCs to assist
CH1 domain folding could be due to the fact that each
possesses an unfolded domain that might interfere with the process.
Since the V and C domains of the surrogate LC of the pre-B cell Ig
receptor are synthesized as separate proteins (VpreB and
5), we determined whether an isolated C domain could
interact with and allow the CH1 domain to fold. We used a
LC construct in which the ER-targeting signal sequence was directly
spliced to the
I constant domain. Cells were transfected with
HA-
CH1 and either WT
or the
CL domain alone (er-C
). While assembly of WT
with the truncated heavy chain was readily observed in coprecipitation experiments (Figure
5), there was no indication that the
isolated CL domain was able to combine with the truncated
heavy chain, as neither protein coprecipitated with the other. When the
culture supernatants of both transfectants were examined, we found that
the isolated C domain could be secreted like the WT
, but unlike the
WT
it did not allow secretion of HA-
CH1 (Figure 5).
Thus, it appears that a LC composed of a folded V and C domain is
required for both final folding of the heavy chain and HL assembly.
|
How Do LCs Facilitate CH1 Domain Folding?
Our data clearly indicate that the CH1 domain is not
folded until it assembles with a LC. We envisioned two models to
explain these data. First, the LC could associate with the heavy chain and in some way displace BiP from the complex, allowing the heavy chain
to fold. Second, BiP might constantly cycle off the CH1 domain, but in the absence of the LC the CH1 domain could
be unable to fold and therefore rebind to BiP. The latter possibility
implies that the folded LC may provide a scaffold on which the
CH1 domain folds. To distinguish between these
possibilities, we asked if the CH1 domain could fold if BiP
was released in vitro. Similar studies have been done with the NS-1
LC, which binds BiP and is not secreted. If cell lysates or immune
complexes are treated with ATP, BiP is released and the NS-1 LC folds
(Knittler et al., 1995
). The NS-1 LC was used as a control
in our experiments. As reported previously, we found that at least half
of the
LC isolated in the presence of the alkylating agent NEM (to
block postlysis oxidation) and absence of ATP is incompletely oxidized
and bound to BiP (Figure 6, lane 1).
However, if ATP is added, BiP is released and the LC folds completely
(Figure 6, lane 3). This is completely consistent with the previous
study in which the LC was isolated from lymphoid cells (Knittler
et al., 1995
). When the truncated heavy chain was examined
in the same way, we found that the partially folded chain (Figure 6,
lane 6) was able to fold completely in the absence of LC if BiP was
released (Figure 6, lane 8). Cells triply transfected with BiP, HC, and
LC served as a control for the migration of the folding intermediates
(lanes 5 and 10). These data demonstrate that the CH1
domain is not intrinsically unable to fold. Instead, the heavy chain
appears to be stably bound to BiP via a CH1 domain that is
unable to fold until a LC is synthesized and available to associate
with the heavy chain.
|
| |
DISCUSSION |
|---|
|
|
|---|
The data provided here reveal the mechanism by which heavy
chains remain continuously associated with BiP until assembly with completely folded LC is achieved. In this way, both the LC and BiP
facilitate proper development and functioning of the B cell repertoire,
as they ensure that incompletely assembled heavy chains remain in the
ER. Simply described, the mechanism involves three steps. First, BiP
interacts with the CH1 domain, a domain that remains
unfolded in free heavy chains. Second, a LC either "catches" the
heavy chain when BiP has cycled off, thereby preventing BiP from
rebinding, or associates with the BiP-heavy chain complex and
"triggers" BiP release. Finally, the CH1 domain is able
to fold and assemble stably with the LC, yielding a transport-competent and functional Ig molecule (Figure 7).
|
Our data argue that complete folding of the heavy chain is dependent on
its assembly with LC and not that assembly of Ig molecules is dependent
on the proper folding of the individual subunits. Assembly-dependent
folding of Ig molecules was previously proposed by Haas and co-workers
(Kaloff and Haas, 1995
; Leitzgen et al., 1997
). Using a
CH1-deleted heavy chain, they demonstrated that BiP could
bind to other Ig heavy-chain domains, but that this interaction was
transient and restricted to unoxidized heavy chains (Kaloff and
Haas, 1995
). They hypothesized that domain pairing between the two
heavy chains promoted their folding and BiP release and that BiP
remained bound to the CH1 domain because it does not
homodimerize but instead pairs with the CL domain of LC.
They further speculated that pairing with LCs would be required to allow the CH1 domain to fold. The data we present provide
direct support for their central hypothesis that folding of Ig domains is dependent on assembly. However, our data further reveal that the
role of LC is not to act as a scaffold, on which the CH1
domain can fold, but instead serves to release BiP from the heavy
chain, since this domain is perfectly capable of folding if BiP is
released in vitro. Although the structure of all Ig domains is
extremely similar, the CH1 domain is clearly distinguished
from the other Ig domains in its requirements for folding. Most of the
other domains appear to fold rapidly and independently of BiP, because expression of the BiP mutants did not greatly affect the folding or
secretion of the CH1-deleted heavy chain (Figure 1B). In
the case of the CH2 and CH3 domains, this may
relate to their ability to homodimerize as mentioned above (Kaloff and
Haas, 1995
). However, the VH domain should also not
homodimerize on an unassembled heavy chain, and yet this domain is
efficiently folded and oxidized in our truncated heavy chain.
Additionally, the observation that some heavy chains with
CH3 domain deletions can be secreted as HL molecules
(Hendershot et al., 1987
) suggests that domain pairing may
not be a strict requirement for the folding of all Ig domains.
We were somewhat surprised to find that only LCs possessing two
folded domains could successfully induce the folding of the CH1 domain. It is possible that the VH and
VL domains pair and form a "semistable" interaction
that allows the CL domain to contact the CH1
domain and in some way displace BiP. Haas's laboratory (Leitzgen
et al., 1997
) has shown that folding of the VL
domain of two mutant, nonsecreted LCs is impaired and can be aided by their heterodimerization with a VH domain during heavy
chain assembly. They suggested that the inability of these mutant LCs
to be secreted is due to their inability to form homodimers. In the
absence of heavy chains, most LCs homodimerize and can be secreted (Ma
et al., 1990
), lending support to this hypothesis. However,
another study (Dul et al., 1996
) identified a number of LCs
that are apparently secreted as monomers, making it unclear whether
assembly is generally essential for LC folding. If the heavy and light
chains do serve to "cross" fold each other, our data from the LC
mutants suggest that assembled intermediates that do not yield
successfully folded products must be rather unstable and fall apart
quickly. The requirement for a LC that is capable of folding both of
its domains to fold the CH1 domain would be particularly
useful in controlling the assembly of the pre-B cell Ig receptor where
each LC domain is provided by a separate protein (i.e.
VpreB and
5) (Sakaguchi and Melchers, 1986
;
Kudo and Melchers, 1987
). This would also provide an additional control
for monitoring the variable region, which can undergo extensive
mutation during Ig repertoire development, to ensure that a LC with an
improperly folded variable region does not assemble with heavy chains
and allow them to be transported. We hypothesize that in pre-B cells
either the surrogate LC complex assembles first and then binds to the
heavy chain or VpreB and
5 bind separately,
but only if both bind to the heavy chain would BiP be displaced and the
CH1 domain allowed to fold. The failure of our ER-targeted
CL domain to combine with the truncated heavy chain might
argue against this second model. However, we cannot rule out the
possibility that a solitary CL domain can interact nonproductively with the CH1 domain and is either too
transient or too weak to withstand the conditions of cell lysis and immunoprecipitation.
The mechanism by which LC releases BiP from the heavy chain is at the
heart of controlling the integrity of the Ig assembly process. Most of
the current data available on mechanisms of molecular chaperone action
come from in vitro studies and suggest that they act to aid protein
folding by continually binding and releasing proteins in a
progressively folded state (Bukau and Horwich, 1998
). Importantly, our
data demonstrate that the CH1 domain is capable of folding
independent of LC if BiP is released (Figure 6). Therefore, if BiP
cycling does occur, it must be faster than the rate of CH1
domain folding, since we found no evidence for the intracellular accumulation of completely folded CH1 domain.
Hsp70 family members are thought to associate with proteins in an
ATP-bound state. The nucleotide is rapidly hydrolyzed to ADP which
"locks" the hsp70 protein more stably to the unfolded protein. This
hydrolysis is catalyzed by a DnaJ-like protein (Liberek et
al., 1991
). Exchange of ATP then allows release of the unfolded protein. In bacteria and mitochondria this nucleotide exchange occurs
through the action of a GrpE protein (Liberek et al., 1991
). In mammalian cytosol, several proteins have been identified that play a
role in regulating nucleotide exchange. An hsp70-interacting protein
(Hip) prevents release of ADP, thus stabilizing the cytosolic hsp70s in
an ADP-bound state (Hohfeld et al., 1995
). Two other proteins, an hsp70 organizing protein (Hop) (Gross and Hessefort, 1996
;
Frydman and Hohfeld, 1997
) and Bag-1 (Hohfeld and Jentsch, 1997
), have
been shown to facilitate nucleotide exchange in vitro. Perhaps a DnaJ
and/or Hip protein are part of the BiP-heavy chain complex in the ER,
which would keep BiP in an ADP-bound form and thus more stably bound to
the CH1 domain. Interaction of the LC with this complex
could diminish its affinity for an ADP-stabilizing component.
Alternatively, the LC may bring another protein (like Hop or Bag-1) to
the BiP-heavy chain complex that would promote nucleotide exchange.
Our ability to release BiP with ATP after the cells have been lysed
could be explained if the association of a DnaJ- or Hip-like protein
was unstable to detergent lysis or if large amounts of exogenously
added ATP were sufficient to drive nucleotide exchange. While such
speculations are reasonable in light of what is known about the action
of hsp70 proteins, it is important to note that no ER homologues for
Hip, Hop, or Bag-1 have been identified in mammalian cells. An
ER-targeted, DnaJ-like protein was identified in mouse cells recently
(Brightman et al., 1995
), but no functional data have been
reported for this protein.
In conclusion, we have provided a clearer understanding of the mechanism(s) ensuring that only completely assembled Ig molecules leave the ER. We have demonstrated that heavy chains do not fold completely in the ER until they assemble with LCs. Because the Ig domain is one of the more commonly used structures in proteins, it is very conceivable that assembly-dependent folding of a protein subunit is not unique to the Ig molecule but represents a commonly used quality-control mechanism to ensure that only properly assembled multimeric proteins are transported from the ER.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by NIH grant GM-54068, the Cancer Center CORE grant CA-21765, and the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. J.W.B. was supported by NIH grant F32 GM-18443.
| |
FOOTNOTES |
|---|
Corresponding author. E-mail
address: linda.hendershot{at}stjude.org.
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
R. Guerin, G. Arseneault, S. Dumont, and L. A. Rokeach Calnexin Is Involved in Apoptosis Induced by Endoplasmic Reticulum Stress in the Fission Yeast Mol. Biol. Cell, October 1, 2008; 19(10): 4404 - 4420. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Awad, I. Estrada, Y. Shen, and L. M. Hendershot BiP mutants that are unable to interact with endoplasmic reticulum DnaJ proteins provide insights into interdomain interactions in BiP PNAS, January 29, 2008; 105(4): 1164 - 1169. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Odinsen, S. Owusu-Ofori, A. Dompreh, F. Sarkodie, O. Opare-Sem, D. Parker, and J.-P. Allain Antibody Detection and Kinetics of Antibody Production during Early Stages of Immunization with Hepatitis B Virus Vaccine Clin. Vaccine Immunol., December 1, 2007; 14(12): 1623 - 1628. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Merz, J.-M. Krause, J. Roig, V. Singh, and P. Berger Nonassembled Human Chorionic Gonadotropin Subunits and {alpha}{alpha}-Homodimers Use Fast-Track Processing in the Secretory Pathway in Contrast to {alpha}{beta}-Heterodimers Endocrinology, December 1, 2007; 148(12): 5831 - 5841. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, C. Zhang, T. Jostock, and S. Dubel Analysis of IgG heavy chain to light chain ratio with mutant Encephalomyocarditis virus internal ribosome entry site Protein Eng. Des. Sel., October 20, 2007; (2007) gzm038v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Davenport, H. E. Moore, A. S. Dunlop, S. Y. Sharp, P. Workman, G. J. Morgan, and F. E. Davies Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells Blood, October 1, 2007; 110(7): 2641 - 2649. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Obeng, L. M. Carlson, D. M. Gutman, W. J. Harrington Jr, K. P. Lee, and L. H. Boise Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells Blood, June 15, 2006; 107(12): 4907 - 4916. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. Schmidt and D. H. Perlmutter Grp78, Grp94, and Grp170 interact with {alpha}1-antitrypsin mutants that are retained in the endoplasmic reticulum Am J Physiol Gastrointest Liver Physiol, September 1, 2005; 289(3): G444 - G455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Elkabetz, Y. Argon, and S. Bar-Nun Cysteines in CH1 Underlie Retention of Unassembled Ig Heavy Chains J. Biol. Chem., April 15, 2005; 280(15): 14402 - 14412. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shen and L. M. Hendershot ERdj3, a Stress-inducible Endoplasmic Reticulum DnaJ Homologue, Serves as a CoFactor for BiP's Interactions with Unfolded Substrates Mol. Biol. Cell, January 1, 2005; 16(1): 40 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Decourt, H. R. Galea, C. Sirac, and M. Cogne Immunologic basis for the rare occurrence of true nonsecretory plasma cell dyscrasias J. Leukoc. Biol., September 1, 2004; 76(3): 528 - 536. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suzuki and Y. C. Lee Site-specific N-glycosylation of chicken serum IgG Glycobiology, March 1, 2004; 14(3): 275 - 292. [Abstract] |